Sign In
Buy TRIB
$0.701
-0.0312 (-4.26%)
At Close: Jun 03, 2026
Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations
09:27am, Friday, 01'st May 2026
- Appointment supports revenue quality and profitability momentum as the Company activates its transformed operating base - Company announces further operational progress in its Comprehensive Transf
Trinity Biotech (TRIB) to Release Earnings on Wednesday
01:08am, Wednesday, 01'st Apr 2026
Trinity Biotech (NASDAQ: TRIB - Get Free Report) is expected to release its Q4 2025 resultson Wednesday, April 8th. Analysts expect Trinity Biotech to post earnings of ($0.32) per share and revenue of
Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test
09:23am, Monday, 23'rd Mar 2026
DUBLIN and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a global diagnostics company, today announced successful results from a clinical study of a new, enhanced ve
CompuMed (OTCMKTS:CMPD) & Trinity Biotech (NASDAQ:TRIB) Head-To-Head Review
02:30am, Sunday, 22'nd Mar 2026
Trinity Biotech (NASDAQ: TRIB - Get Free Report) and CompuMed (OTCMKTS:CMPD - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on th
Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren's Syndrome
08:30am, Wednesday, 18'th Mar 2026
DUBLIN and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, inc
Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointment DUBLIN, March 12, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech p
Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program
09:00am, Wednesday, 11'th Mar 2026
DUBLIN and WILSONVILLE, Ore., March 11, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solut
Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform
07:55am, Tuesday, 10'th Mar 2026
- Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronic
Trinity Biotech Provides Business and Trading Update
07:45am, Tuesday, 10'th Mar 2026
DUBLIN, March 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearab
Critical Review: Trinity Biotech (NASDAQ:TRIB) vs. Ayr Wellness (OTCMKTS:AYRWF)
01:54am, Tuesday, 10'th Mar 2026
Ayr Wellness (OTCMKTS:AYRWF - Get Free Report) and Trinity Biotech (NASDAQ: TRIB - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based
Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
09:00am, Wednesday, 25'th Feb 2026
- Agreement provides additional funding tool of up to $25 million over a period of up to 36 months - Underpins the Company's ambitions to expand its commercialisation activities and advance its innova
DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearabl
DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearabl
DUBLIN, Ireland, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, includin
– Reinforces Trinity Biotech's growing position as a key player in diabetes care innovation – Senior commercial executives of Trinity Biotech are attending the World Health Expo from February 10-1
